PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.98%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-10.41%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-26.33%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-26.33%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.97%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-12.50%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.35%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
22.65%
Dividend growth above 1.5x ADI's 0.35%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
38.54%
OCF growth above 1.5x ADI's 8.57%. David Dodd would confirm a clear edge in underlying cash generation.
78.76%
FCF growth above 1.5x ADI's 10.44%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-2.53%
Negative 10Y revenue/share CAGR while ADI stands at 289.21%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
16.81%
5Y revenue/share CAGR under 50% of ADI's 36.40%. Michael Burry would suspect a significant competitive gap or product weakness.
63.75%
3Y revenue/share CAGR 1.25-1.5x ADI's 44.39%. Bruce Berkowitz might see better product or regional expansions than the competitor.
160.39%
10Y OCF/share CAGR at 50-75% of ADI's 219.76%. Martin Whitman might fear a structural deficiency in operational efficiency.
34.06%
5Y OCF/share CAGR above 1.5x ADI's 3.75%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
55.27%
3Y OCF/share CAGR above 1.5x ADI's 20.36%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
124.14%
Below 50% of ADI's 662.98%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
7.41%
Below 50% of ADI's 68.08%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
492.03%
3Y net income/share CAGR 1.25-1.5x ADI's 428.47%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
269.66%
Below 50% of ADI's 811.32%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
41.08%
Below 50% of ADI's 118.71%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.06%
Below 50% of ADI's 29.23%. Michael Burry suspects a serious short-term disadvantage in building book value.
64.52%
Dividend/share CAGR of 64.52% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
29.35%
Dividend/share CAGR of 29.35% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
13.43%
3Y dividend/share CAGR of 13.43% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-13.69%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-7.37%
Inventory is declining while ADI stands at 6.01%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.00%
Asset growth above 1.5x ADI's 0.17%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.65%
BV/share growth above 1.5x ADI's 0.93%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.04%
We’re deleveraging while ADI stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.04%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.72%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.